Progress in the development of immunotherapy for the treatment of patients with cancer

Journal of Internal Medicine
S A Rosenberg

Abstract

Several recent developments have hallmarked progress in tumour immunology and immunotherapy. The use of interleukin-2 (IL-2) in cancer patients demonstrated that an immunological manipulation was capable of mediating the regression of established growing cancers in humans. The identification of the genes encoding cancer antigens and the development of means for effectively immunizing patients against these antigens has opened important new avenues of exploration for the development of effective active and cell-transfer immunotherapies for patients with cancer.

References

May 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L TopalianP Simon
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FyfeA C Louie
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·M TheobaldL A Sherman
Mar 1, 1996·The Journal of Experimental Medicine·R F WangS A Rosenberg
Mar 1, 1996·The Journal of Experimental Medicine·P F RobbinsS A Rosenberg
Dec 1, 1996·The Journal of Experimental Medicine·R F WangS A Rosenberg
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Jun 1, 1997·Immunology Today·T BoonB Van den Eynde
Mar 2, 1999·The Journal of Experimental Medicine·R PieperS L Topalian
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Mar 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C E TouloukianN P Restifo
Apr 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·B MinevM Zanetti
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G ZengR F Wang
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y KawakamiS Rosenberg

❮ Previous
Next ❯

Citations

Feb 25, 2005·Springer Seminars in Immunopathology·Morgan E Wallace, Mark J Smyth
Apr 4, 2007·Cancer Metastasis Reviews·D LukashevM Sitkovsky
Apr 12, 2008·Purinergic Signalling·Dmitriy LukashevAkio Ohta
Jun 24, 2004·Human Gene Therapy·John StaggJacques Galipeau
Dec 4, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Masaharu Shin-YaMinoru Takeuchi
Nov 4, 2008·Cancer Biotherapy & Radiopharmaceuticals·Akiva MintzWaldemar Debinski
Jul 26, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Michael Francis JohnstonWenhui Li
Jun 24, 2003·Genome Research·Vladimir BrusicUNKNOWN GSL Members
Mar 23, 2006·Annual Review of Immunology·Thierry BoonPierre van der Bruggen
Sep 2, 2008·Cancer Research·Weiyi PengRong-Fu Wang
Apr 23, 2003·American Journal of Respiratory Cell and Molecular Biology·Jeffrey L Curtis, Antonello Punturieri
Feb 1, 2012·Clinical & Developmental Immunology·Sapoznik SivanLotem Michal
Aug 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Akio OhtaMichail Sitkovsky
Jul 10, 2010·Journal of Biomedicine & Biotechnology·Yuzuru IkeharaTakashi Yamaguchi
Mar 14, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Masaharu HataTomio Inoue
May 10, 2011·Cancer Immunology, Immunotherapy : CII·Arcadi CipponiPierre G Coulie
Jun 16, 2012·Clinical and Experimental Medicine·Karen Brajão de OliveiraMaria Angelica Ehara Watanabe
Feb 14, 2008·Expert Opinion on Therapeutic Targets·Ming-Hua ZhengYong-Ping Chen
Sep 30, 2008·Scandinavian Journal of Gastroenterology·Stefan K BurgdorfJacob Rosenberg
Jul 30, 2005·Expert Opinion on Biological Therapy·Volker Schirrmacher
Jan 20, 2012·Seminars in Cancer Biology·Arya Biragyn, Dan L Longo
Jan 11, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dalit Landesman-Milo, Dan Peer
Feb 19, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Martina KubecovaVladimir Bobek
Jun 4, 2004·The Journal of Investigative Dermatology·Friederike FellenbergStefan Eichmüller
Mar 5, 2004·The British Journal of Dermatology·T B HartmannS Eichmüller
Mar 4, 2008·British Journal of Pharmacology·M SitkovskyA Ohta
Jul 3, 2013·International Journal of Cancer. Journal International Du Cancer·Mei-Ling ChenAnn-Lii Cheng
Sep 30, 2004·International Immunopharmacology·P K Raveendran NairCheppail Ramachandran
Sep 13, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Isabel BaraoWilliam J Murphy
Jan 18, 2006·Cancer Letters·Isaac P Witz, Orlev Levy-Nissenbaum
Apr 1, 2004·International Journal of Cancer. Journal International Du Cancer·Daniela MontagnaRita Maccario
Jun 8, 2018·Expert Opinion on Biological Therapy·Lorenzo PillaCristina Maccalli
Feb 1, 2006·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ping Yu, Yang-Xin Fu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.